title: Editorial: how to interpret risks and prediction of complications in Crohn's disease--can our patients interpret them? Authors' reply.
authors: Dartmouth-Hitchcock Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. corey.a.siegel@hitchcock.org.
authors: C A
authors: CA
authors: Siegel
authors: Icahn School of Medicine at Mt. Sinai, New York, NY, USA.
authors: M C
authors: MC
authors: Dubinsky
mesh_terms: D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D020407:Internet; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha